Literature DB >> 1729816

Ventricular thrombi and thromboembolism in dilated cardiomyopathy: a prospective follow-up study.

R H Falk1, E Foster, M H Coats.   

Abstract

To determine the prevalence and natural history of left ventricular thrombus in dilated cardiomyopathy, we prospectively performed two-dimensional echocardiograms in 25 patients with nonischemic dilated cardiomyopathy who were not receiving anticoagulation. Eighty-five echocardiograms were performed serially over a 9- to 30-month period (mean follow-up 21.5 months). A left ventricular thrombus was present on initial echocardiogram in 11 (44%) patients, became present during follow-up in an additional four, and disappeared in two. Thrombus was significantly more common in patients with fractional shortening of less than or equal to 10% (12 of 15) than in those with a fractional shortening 11% to 25% (3 of 10) (p less than 0.02). Five embolic events (four cerebral) occurred over the follow-up period, four of which were associated with a previously visualized left ventricular thrombus. Three of five thrombi that protruded into the left ventricular cavity subsequently embolized. We conclude that in nonanticoagulated patients with dilated cardiomyopathy left ventricular thrombus and thromboembolism are common. Echocardiography may be helpful in predicting which patients are at risk of thromboembolism.

Entities:  

Mesh:

Year:  1992        PMID: 1729816     DOI: 10.1016/0002-8703(92)90757-m

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  22 in total

Review 1.  Intracardiac thrombus formation in cardiac impairment: the role of anticoagulant therapy.

Authors:  G Y Lip
Journal:  Postgrad Med J       Date:  1996-12       Impact factor: 2.401

2.  Presentation, management and outcomes of thrombosis for children with cardiomyopathy.

Authors:  Brian W McCrindle; Tara Karamlou; Harvey Wong; Nirupama Gangam; Kalyani R Trivedi; Kyong-Jin Lee; Lee N Benson
Journal:  Can J Cardiol       Date:  2006-06       Impact factor: 5.223

3.  Anticoagulation in Congestive Cardiomyopathy: Steps Toward Defining the Great Unknown.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

4.  Preventive health care, 1999 update: 2. Echocardiography for the detection of a cardiac source of embolus in patients with stroke. Canadian Task Force on Preventive Health Care.

Authors:  M K Kapral; F L Silver
Journal:  CMAJ       Date:  1999-10-19       Impact factor: 8.262

5.  Thromboembolic risk in the patient with heart failure.

Authors:  Liviu Klein; John B O'connell
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-08

Review 6.  Treatment of end stage dilated cardiomyopathy.

Authors:  J B O'Connell; C K Moore; H C Waterer
Journal:  Br Heart J       Date:  1994-12

7.  Interactions between cardiovascular and cerebrovascular disease.

Authors:  Giuseppe Di Pasquale; Stefano Urbinati; Enrica Perugini; Simona Gambetti
Journal:  Curr Treat Options Neurol       Date:  2012-12       Impact factor: 3.598

8.  A single-center experience with intracardiac thrombosis in children with dilated cardiomyopathy.

Authors:  Soo-Han Choi; Soo In Jeong; Ji-Hyuk Yang; I-Seok Kang; Tae-Gook Jun; Heung-Jae Lee; June Huh
Journal:  Pediatr Cardiol       Date:  2010-02       Impact factor: 1.655

9.  Fibrinolytic treatment in left ventricular mobile thrombi with low ejection fraction: results and follow-up of seven cases.

Authors:  Ibrahim Sari; Vedat Davutoğlu; Serdar Soydinc; Murat Sucu; Orhan Ozer
Journal:  J Thromb Thrombolysis       Date:  2007-05-11       Impact factor: 2.300

10.  Pheochromocytoma underlying hypertension, stroke, and dilated cardiomyopathy.

Authors:  Pi Chi Lin; Jen Te Hsu; Chang Min Chung; Shih Tai Chang
Journal:  Tex Heart Inst J       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.